Home » Newsletters » BioWorld

BioWorld

Sep. 10, 1993

View Archived Issues

QUIDEL ACQUIRES PRODUCT LINE

ELAN PAYS IPIC $5.4M FOR PARKINSON'S PRODUCT

EPSTEIN-BARR VIRUS PATENT ISSUED

NEOPROBE EXPANDS CANCER THERAPY TRIALS

ZADAXIN APPROVED IN SINGAPORE

VERTEX LINKS UP WITH ROUSSEL IN $30M AGREEMENT

RAC APPROVES FOUR PROTOCOLS

NEOCRIN, CYTOTHERAPEUTICS MERGE RESEARCH

IMMUNOPHARMACEUTICS GETS SBIR FOR ALZHEIMER'S

COGNEX APPROVED BY FDA

CELLEX ANNOUNCES DISTRIBUTION AGREEMENT

CELTRIX FOUNDER BRUCE PHARRISS DIES

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026